Latest uK
Guidance for new Marketing Authorisation assessment routes in the UK following Brexit: International routes

In the last of our series of posts analysing the new access routes developed in the UK, Nasos Kipentzoglou, Analyst at Lightning Health takes an in-depth look at the international routes; the Access Consortium and Project Orbis

Guidance for new Marketing Authorisation assessment routes in the UK following Brexit: Unfettered Access Procedure for marketing authorisations approved in Northern Ireland

In the penultimate of our series of posts analysing the new access routes developed in the UK, Nasos Kipentzoglou, Analyst at Lightning Health takes a deeper dive into the Unfettered Access Procedure for marketing authorisations approved in Northern Ireland 

Guidance for new Marketing Authorisation assessment routes in the UK following Brexit: Decentralised and Mutual Recognition Reliance Procedure

In the fourth of our series of posts analysing the new access routes developed in the UK, Nasos Kipentzoglou, Analyst at Lightning Health takes a deeper dive into the Decentralised and Mutual Recognition Reliance Procedure 

Guidance for new Marketing Authorisation assessment routes in the UK following Brexit: European Commission (EC) Decision reliance procedure

In the third of our series of posts analysing the new access routes developed in the UK, Nasos Kipentzoglou, Analyst at Lightning Health looks at the European Commission Decision reliance procedure

Guidance for new Marketing Authorisation assessment routes in the UK following Brexit: rolling review procedure

In the second of our series of posts analysing the new access routes developed in the UK, Nasos Kipentzoglou, Analyst at Lightning Health takes a deeper dive into the rolling review procedure

Guidance for new Marketing Authorisation assessment routes in the UK following Brexit: 150-day National Procedure

In the first of a series of articles looking at the mechanisms to obtain marketing authorisation in the UK, Nasos Kipentzoglou, Analyst at Lightning Health takes an in-depth look at the 150-day National Procedure and the possible implications for manufacturers

Guidance for new Marketing Authorisation assessment routes in the UK following Brexit

In the intro of a series of articles, Nasos Kipentzoglou, Analyst at Lightning Health provides a round up of the current mechanisms to obtain marketing authorisation in the UK